Bg pattern

CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for theuser

Clopidogrel Mylan 75 mg film-coated tabletsEFG

clopidogrel

Read the entire package leaflet carefully before starting to take the medicine, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medicine has been prescribed to you only, and you should not give it to others, even if they have the same symptoms, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the package leaflet

  1. What is Clopidogrel Mylan and what is it used for
  2. What you need to know before taking Clopidogrel Mylan
  3. How to take Clopidogrel Mylan
  4. Possible side effects

5 Storage of Clopidogrel Mylan

  1. Package contents and additional information

1. What is Clopidogrel Mylan and what is it used for

Clopidogrel Mylan contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells that are found in the blood and clump together when the blood clots. Antiplatelet agents prevent this clumping, reducing the risk of blood clots (a process called thrombosis) forming.

Clopidogrel Mylan is given to adults to prevent the formation of blood clots (thrombi) in blood vessels (arteries) that have become hardened, a process known as atherothrombosis, which can cause atherothrombotic events (such as stroke, myocardial infarction, or death).

You have been prescribed Clopidogrel Mylan to help prevent the formation of blood clots and reduce the risk of these serious events because:

  • You have a condition that causes hardening of the arteries (also called atherothrombosis), and
  • You have previously had a myocardial infarction, stroke, or suffer from a disease called peripheral arterial disease, or
  • You have had a severe type of chest pain, known as "unstable angina" or "myocardial infarction". For the treatment of this disease, your doctor may need to place a stent in the blocked or narrowed artery to restore proper blood flow. Your doctor may also have prescribed acetylsalicylic acid (a substance found in many medications used to relieve pain and reduce fever, as well as to prevent blood clots).

You have an irregular heartbeat, a condition called "atrial fibrillation", and you cannot take medications known as "oral anticoagulants" (vitamin K antagonists) that prevent the formation of new clots and prevent the growth of existing clots. You will have been told that "oral anticoagulants" are more effective than acetylsalicylic acid or the combined use of Clopidogrel Mylan and acetylsalicylic acid for this disease. Your doctor will have prescribed Clopidogrel Mylan plus acetylsalicylic acid if you cannot take "oral anticoagulants" and do not have a risk of severe bleeding.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Clopidogrel Mylan

Do not take Clopidogrel Mylan:

  • If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6).
  • If you have an active bleeding disorder, such as a stomach ulcer or bleeding in the brain;
  • If you have a severe liver disease.

If you think any of these may apply to you, or if you are unsure, consult your doctor before taking Clopidogrel Mylan.

Warnings and precautions

Before starting treatment with Clopidogrel Mylan, inform your doctor if you are in any of the following situations:

  • If you have a risk of bleeding (bleeding) because:
  • You have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
  • You have a blood disorder that predisposes you to internal bleeding (bleeding in tissues, organs, or joints of the body).
  • You have recently had a serious injury.
  • You have recently undergone surgery (including dental surgery).
  • You are scheduled to undergo surgery (including dental surgery) within the next seven days.
  • If you have had a blood clot in an artery of the brain (ischemic stroke) in the last 7 days.
  • If you have liver or kidney disease.
  • If you have had an allergy or reaction to any medication used to treat your disease.

During treatment with Clopidogrel Mylan:

  • Inform your doctor if you are scheduled to undergo surgery (including dental surgery).
  • Inform your doctor immediately if you develop a disorder (also known as Thrombotic Thrombocytopenic Purpura or TTP) that includes fever and bruising (bleeding under the skin that can appear as red spots), accompanied or not by unexplained extreme fatigue, confusion, yellowing of the skin or eyes (jaundice) (see section 4 "Possible side effects").
  • If you cut or injure yourself, bleeding may take longer than usual to stop. This is related to the way the medicine works, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cutting yourself while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
  • Your doctor may ask you to have blood tests.

Use in children and adolescents

Do not give this medicine to children as it has no effect.

Other medicines and Clopidogrel Mylan

Inform your doctor or pharmacist if you are using, have recently used, or may need to use other medicines, including those obtained without a prescription.

Some medicines may affect the use of Clopidogrel Mylan or vice versa.

You must explicitly inform your doctor if you are taking:

  • medicines that may increase the risk of bleeding, such as:
  • oral anticoagulants, medicines used to decrease blood clotting,
    • non-steroidal anti-inflammatory drugs, medicines used to treat pain and/or inflammation of muscles or joints,
  • heparin, or any other injectable medicine used to decrease blood clotting,
  • ticlopidine, another antiplatelet agent,
  • a serotonin reuptake inhibitor (such as fluoxetine or fluvoxamine and other medications of the same type), medicines used to treat depression,
    • omeprazole or esomeprazole, medicines used to treat stomach discomfort,
    • fluconazole or voriconazole, medicines used to treat fungal infections,
    • efavirenz, a medicine used to treat HIV (human immunodeficiency virus) infections,
    • carbamazepine, a medicine used to treat some forms of epilepsy,
    • moclobemide, a medicine used to treat depression,
    • repaglinide, a medicine used to treat diabetes,
    • paclitaxel, a medicine used to treat cancer.

If you have had severe chest pain (unstable angina or myocardial infarction), you may have been prescribed Clopidogrel Mylan in combination with acetylsalicylic acid, a substance found in many medications used to relieve pain and reduce fever. A dose of acetylsalicylic acid administered occasionally (not exceeding 1,000 mg in 24 hours) is generally not a problem, but prolonged use in other circumstances should be discussed with your doctor.

Pregnancy and breastfeeding

It is preferable not to take this medicine during pregnancy.

If you are pregnant or think you may be pregnant, you should inform your doctor or pharmacist before taking Clopidogrel Mylan. If you become pregnant while taking Clopidogrel Mylan, consult your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.

Do not breastfeed while taking this medicine.

If you are breastfeeding or plan to breastfeed, inform your doctor before taking this medicine.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

It is unlikely that Clopidogrel Mylan will affect your ability to drive or operate machines.

Clopidogrel Mylan contains hydrogenated castor oil

This may cause stomach upset or diarrhea.

3. How to take Clopidogrel Mylan

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

The recommended dose, even for patients with a condition called "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Mylan per day, taken orally with or without food, and at the same time each day.

If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe 300 mg of Clopidogrel Mylan (4 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Mylan per day, as described above.

You should take Clopidogrel Mylan for as long as your doctor continues to prescribe it.

If you take more Clopidogrel Mylan than you should

Contact your doctor or go to the nearest hospital emergency department, as there is an increased risk of bleeding.

If you forget to take Clopidogrel Mylan

If you forget to take a dose of Clopidogrel Mylan, but remember before 12 hours have passed since the time you should have taken the medicine, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for the missed tablet.

For pack sizes of 7, 14, 28, 56, 84 tablets (calendar blister), you can check the day you took the last tablet of Clopidogrel Mylan by referring to the calendar printed on the blister.

If you stop taking Clopidogrel Mylan

Do not stop your treatment unless your doctor tells you to. Contact your doctor or pharmacist before stopping this medicine.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately if you experience:

  • Fever, signs of infection, or severe fatigue. These symptoms may be due to a rare decrease in some blood cells.
  • Signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), associated or not with bleeding that appears under the skin as red spots and/or confusion (see section 2 "Warnings and precautions").
  • Swelling of the mouth or skin disorders such as rashes and itching, blisters on the skin. These can be signs of an allergic reaction.

The most common side effect reported with Clopidogrel Mylan is bleeding.

Bleeding can occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding from the blood vessels of the eyes, intracranial, pulmonary, or joint bleeding have also been reported.

If you experience prolonged bleeding while taking Clopidogrel Mylan

If you cut or injure yourself, bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood's ability to form clots. For minor cuts or injuries, such as cutting yourself while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").

Other side effects reported are:

Common side effects (may affect up to 1 in 10 people): Diarrhea, abdominal pain, indigestion, or heartburn.

Uncommon side effects (may affect up to 1 in 100 people):

Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling, and numbness.

Rare side effects (may affect up to 1 in 1,000 people):

Dizziness, breast enlargement in men.

Very rare side effects (may affect up to 1 in 10,000 people):

Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., general feeling of heat with general discomfort up to sudden fainting); swelling of the mouth; blisters on the skin, skin allergy; mouth ulcers (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.

Side effects with unknown frequency (cannot be estimated from available data): Hypersensitivity reactions with chest or abdominal pain.

Your doctor may also observe changes in the results of your blood or urine tests.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Clopidogrel Mylan

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and blister after EXP. The expiry date is the last day of the month indicated.

Store in the original packaging to protect from light and moisture.

Do not throw any medicine down the drain or into the trash. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package Contents and Additional Information

Clopidogrel Mylan Composition

The active ingredient is clopidogrel. Each film-coated tablet contains 75 mg of clopidogrel (as hydrochloride).

The other ingredients are:

  • Tablet core: microcrystalline cellulose, anhydrous colloidal silica, crospovidone (type A), macrogol 6000, hydrogenated castor oil (see section 2 'Clopidogrel Mylan contains hydrogenated castor oil').
  • Tablet coating: polyvinyl alcohol, titanium dioxide (E171), red iron oxide (E172), yellow iron oxide (E172), talc, and macrogol 3000.

Appearance of Clopidogrel Mylan and Package Contents

Film-coated tablets are pink, round, and biconvex.

Boxes of 7, 14, 28, 30, 50, 56, 84, 90, and 100 film-coated tablets in blisters are available.

Calendar blisters of 7, 14, 28, 56, 84 film-coated tablets are available. Boxes of 30x1 and 50x1 film-coated tablets in perforated monodose blisters are available.

Only some pack sizes may be marketed.

Marketing Authorization Holder

Mylan S.A.S., 117 allée des Parcs, 69800 Saint Priest, France

Manufacturers

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

TAD Pharma GmbH, Heinz-Lohmann-Strasse 5, 27472 Cuxhaven, Germany

For more information about this medicinal product, please contact the local representative of the marketing authorization holder:

Belgium/Belgique/Belgien

Mylan bvba/sprl

Tel: + 32 (0)2 658 61 00

Lithuania

BGP Products UAB

Tel: +370 5 205 1288

Bulgaria

Mylan Bulgaria EOOD

Tel: +359 2 44 55 400

Luxembourg/Luxemburg

Mylan bvba/sprl

Tel: + 32 (0)2 658 61 00

(Belgium)

Czech Republic

Mylan Pharmaceuticals s.r.o.

Tel: + 420 222 004 400

Hungary

Mylan EPD Kft

Tel: + 36 1 465 2100

Denmark

Mylan AB

Tel: + 46 855 522 750

(Sweden)

Malta

V.J. Salomone Pharma Ltd

Tel: + 356 21 22 01 74

Germany

Mylan dura GmbH

Tel: + 49-(0) 61 72 888 01

Netherlands

Mylan B.V

Tel: + 31 (0) 20 426 3300

Estonia

BGP Products Switzerland GmbH Estonian branch

Tel: + 372 6363 052

Norway

Mylan AB

Tlf: + 46 855 522 750

(Sweden)

Greece

Generics Pharma Hellas ΕΠΕ

Tel: +30 210 993 6410

Austria

Arcana Arzneimittel GmbH

Tel: +43 1 416 24 18

Spain

Mylan Pharmaceuticals, S.L

Tel: + 34 900 102 712

Poland

Mylan Healthcare Sp.z.o.o

Tel: +48 22 546 64 00

France

Mylan SAS

Tel: +33 4 37 25 75 00

Portugal

Mylan, Lda.

Tel: + 351 21 412 72 56

Croatia

Mylan Hrvatska d.o.o.

Tel: +385 1 23 50 599

Romania

BGP Products SRL

Tel: +40 372 579 000

Ireland

Mylan Ireland

+353 (0) 87 1694982

Slovenia

GSP Proizvodi d.o.o.

Tel: + 386 1 236 31 85

Iceland

Mylan AB

Tel: + 46 855 522 750

(Sweden)

Slovak Republic

Mylan s.r.o

Tel: +421 2 32 199 100

Italy

Mylan S.p.A

Tel: + 39 02 612 46921

Finland

Mylan OY

Puh/Tel: + 358 20 720 9555

Cyprus

Pharmaceutical Trading Co Ltd

Tel: + 357 99403969

Sweden

Mylan AB

Tel: + 46 855 522 750

Latvia

BGP Products SIA

Tel: +371 676 055 80

United Kingdom

Generics [UK] Ltd

Tel: +44 1707 853000

Date of Last Revision of this Leaflet: MM/YYYY

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.

Online doctors for CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS

Discuss questions about CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS?
The active ingredient in CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS is clopidogrel. This information helps identify medicines with the same composition but different brand names.
Who manufactures CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS is manufactured by Taw Pharma (Ireland) Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CLOPIDOGREL TAW PHARMA 75 mg FILM-COATED TABLETS?
Other medicines with the same active substance (clopidogrel) include AGRELAN 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALMUS 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALTER 75 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media